Antidepressant use and cognitive decline in community-dwelling elderly people – The Three-City Cohort
Abstract Background Cognitive impairment is very common in late-life depression, principally affecting executive skills and information processing speed. The aim of the study was to examine the effect of antidepressant treatment on cognitive performances over a 10-year period. Methods The community-...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-017-0847-z |
id |
doaj-d5c26c543b2940d3bfefd8978d5bb2e5 |
---|---|
record_format |
Article |
spelling |
doaj-d5c26c543b2940d3bfefd8978d5bb2e52020-11-25T01:41:48ZengBMCBMC Medicine1741-70152017-04-011511910.1186/s12916-017-0847-zAntidepressant use and cognitive decline in community-dwelling elderly people – The Three-City CohortIsabelle Carrière0Joanna Norton1Amandine Farré2Marilyn Wyart3Christophe Tzourio4Pernelle Noize5Karine Pérès6Annie Fourrier-Réglat7Karen Ritchie8Marie Laure Ancelin9Inserm U1061, Neuropsychiatry: epidemiological and clinical researchInserm U1061, Neuropsychiatry: epidemiological and clinical researchInserm U1061, Neuropsychiatry: epidemiological and clinical researchDepartment of Psychiatry, CHU CaremeauUniv. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219Inserm U1061, Neuropsychiatry: epidemiological and clinical researchInserm U1061, Neuropsychiatry: epidemiological and clinical researchAbstract Background Cognitive impairment is very common in late-life depression, principally affecting executive skills and information processing speed. The aim of the study was to examine the effect of antidepressant treatment on cognitive performances over a 10-year period. Methods The community-based cohort included 7381 participants aged 65 years and above. Five cognitive domains (verbal fluency, psychomotor speed, executive function, visuospatial skills and global cognition) were assessed up to five times over 10 years of follow-up. Treatment groups included participants under a specific antidepressant class at both baseline and the first follow-up and their follow-up cognitive data were considered until the last consecutive follow-up with a report of antidepressant use of the same class. Linear mixed models were used to compare baseline cognitive performance and cognitive decline over time according to antidepressant treatment. The models were adjusted for multiple confounders including residual depressive symptoms assessed by the Center for Epidemiologic Studies-Depression scale. Results At baseline, 4.0% of participants were taking antidepressants. Compared to non-users, tricyclic antidepressant users had lower baseline performances in verbal fluency, visual memory and psychomotor speed, and selective serotonin reuptake inhibitor users in verbal fluency and psychomotor speed. For the two other cognitive abilities, executive function and global cognition, no significant differences were found at baseline irrespective of the antidepressant class. Regarding changes over time, no significant differences were observed in comparison with non-users whatever the cognitive domain, except for a slight additional improvement over the follow-up in verbal fluency skills for tricyclic antidepressant users. Conclusions In this large elderly general population cohort, we found no evidence for an association between antidepressant use and post-treatment cognitive decline over 10 years of follow-up in various cognitive domains.http://link.springer.com/article/10.1186/s12916-017-0847-zAntidepressantsCognitionElderly peopleCohort study |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Isabelle Carrière Joanna Norton Amandine Farré Marilyn Wyart Christophe Tzourio Pernelle Noize Karine Pérès Annie Fourrier-Réglat Karen Ritchie Marie Laure Ancelin |
spellingShingle |
Isabelle Carrière Joanna Norton Amandine Farré Marilyn Wyart Christophe Tzourio Pernelle Noize Karine Pérès Annie Fourrier-Réglat Karen Ritchie Marie Laure Ancelin Antidepressant use and cognitive decline in community-dwelling elderly people – The Three-City Cohort BMC Medicine Antidepressants Cognition Elderly people Cohort study |
author_facet |
Isabelle Carrière Joanna Norton Amandine Farré Marilyn Wyart Christophe Tzourio Pernelle Noize Karine Pérès Annie Fourrier-Réglat Karen Ritchie Marie Laure Ancelin |
author_sort |
Isabelle Carrière |
title |
Antidepressant use and cognitive decline in community-dwelling elderly people – The Three-City Cohort |
title_short |
Antidepressant use and cognitive decline in community-dwelling elderly people – The Three-City Cohort |
title_full |
Antidepressant use and cognitive decline in community-dwelling elderly people – The Three-City Cohort |
title_fullStr |
Antidepressant use and cognitive decline in community-dwelling elderly people – The Three-City Cohort |
title_full_unstemmed |
Antidepressant use and cognitive decline in community-dwelling elderly people – The Three-City Cohort |
title_sort |
antidepressant use and cognitive decline in community-dwelling elderly people – the three-city cohort |
publisher |
BMC |
series |
BMC Medicine |
issn |
1741-7015 |
publishDate |
2017-04-01 |
description |
Abstract Background Cognitive impairment is very common in late-life depression, principally affecting executive skills and information processing speed. The aim of the study was to examine the effect of antidepressant treatment on cognitive performances over a 10-year period. Methods The community-based cohort included 7381 participants aged 65 years and above. Five cognitive domains (verbal fluency, psychomotor speed, executive function, visuospatial skills and global cognition) were assessed up to five times over 10 years of follow-up. Treatment groups included participants under a specific antidepressant class at both baseline and the first follow-up and their follow-up cognitive data were considered until the last consecutive follow-up with a report of antidepressant use of the same class. Linear mixed models were used to compare baseline cognitive performance and cognitive decline over time according to antidepressant treatment. The models were adjusted for multiple confounders including residual depressive symptoms assessed by the Center for Epidemiologic Studies-Depression scale. Results At baseline, 4.0% of participants were taking antidepressants. Compared to non-users, tricyclic antidepressant users had lower baseline performances in verbal fluency, visual memory and psychomotor speed, and selective serotonin reuptake inhibitor users in verbal fluency and psychomotor speed. For the two other cognitive abilities, executive function and global cognition, no significant differences were found at baseline irrespective of the antidepressant class. Regarding changes over time, no significant differences were observed in comparison with non-users whatever the cognitive domain, except for a slight additional improvement over the follow-up in verbal fluency skills for tricyclic antidepressant users. Conclusions In this large elderly general population cohort, we found no evidence for an association between antidepressant use and post-treatment cognitive decline over 10 years of follow-up in various cognitive domains. |
topic |
Antidepressants Cognition Elderly people Cohort study |
url |
http://link.springer.com/article/10.1186/s12916-017-0847-z |
work_keys_str_mv |
AT isabellecarriere antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT joannanorton antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT amandinefarre antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT marilynwyart antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT christophetzourio antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT pernellenoize antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT karineperes antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT anniefourrierreglat antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT karenritchie antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort AT marielaureancelin antidepressantuseandcognitivedeclineincommunitydwellingelderlypeoplethethreecitycohort |
_version_ |
1725039681173716992 |